Literature DB >> 19451354

Microparticles from ischemic muscle promotes postnatal vasculogenesis.

Aurelie S Leroyer1, Téni G Ebrahimian, Clément Cochain, Alice Récalde, Olivier Blanc-Brude, Barend Mees, José Vilar, Alain Tedgui, Bernard I Levy, Giovanna Chimini, Chantal M Boulanger, Jean-Sébastien Silvestre.   

Abstract

BACKGROUND: We hypothesized that microparticles (MPs) released after ischemia are endogenous signals leading to postischemic vasculogenesis. METHODS AND
RESULTS: MPs from mice ischemic hind-limb muscle were detected by electron microscopy 48 hours after unilateral femoral artery ligation as vesicles of 0.1- to 1-microm diameter. After isolation by sequential centrifugation, flow cytometry analyses showed that the annexin V(+) MP concentration was 3.5-fold higher in ischemic calves than control muscles (1392+/-406 versus 394+/-180 annexin V(+) MPs per 1 mg; P<0.001) and came mainly from endothelial cells (71% of MPs are CD(144+)). MPs isolated from ischemic muscles induced more potent in vitro bone marrow-mononuclear cell (BM-MNC) differentiation into cells with endothelial phenotype than those isolated from control muscles. MPs isolated from atherosclerotic plaques were ineffective, whereas those isolated from apoptotic or interleukin-1beta-activated endothelial cells also promoted BM-MNC differentiation. Interestingly, MPs from ischemic muscles produced more reactive oxygen species and expressed significantly higher levels of NADPH oxidase p47 (6-fold; P<0.05) and p67 subunits (16-fold; P<0.001) than controls, whereas gp91 subunit expression was unchanged. BM-MNC differentiation was reduced by 2-fold with MPs isolated from gp91-deficient animals compared with wild-type mice (P<0.05). MP effects on postischemic revascularization were then examined in an ischemic hind-limb model. MPs isolated from ischemic muscles were injected into ischemic legs in parallel with venous injection of BM-MNCs. MPs increased the proangiogenic effect of BM-MNC transplantation, and this effect was blunted by gp91 deficiency. In parallel, BM-MNC proangiogenic potential also was reduced in ABCA1 knockout mice with impaired vesiculation.
CONCLUSIONS: MPs produced during tissue ischemia stimulate progenitor cell differentiation and subsequently promote postnatal neovascularization.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19451354     DOI: 10.1161/CIRCULATIONAHA.108.816710

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  47 in total

Review 1.  Circulating microRNAs in cardiovascular diseases: from biomarkers to therapeutic targets.

Authors:  Feng Wang; Chen Chen; Daowen Wang
Journal:  Front Med       Date:  2014-12-01       Impact factor: 4.592

Review 2.  Microparticles and cardiovascular diseases.

Authors:  Christos Voukalis; Eduard Shantsila; Gregory Y H Lip
Journal:  Ann Med       Date:  2019-06-17       Impact factor: 4.709

Review 3.  Influence of red blood cell-derived microparticles upon vasoregulation.

Authors:  Ahmed S Said; Allan Doctor
Journal:  Blood Transfus       Date:  2017-05-15       Impact factor: 3.443

Review 4.  Circulating membrane-derived microvesicles in redox biology.

Authors:  Michael Craig Larson; Cheryl A Hillery; Neil Hogg
Journal:  Free Radic Biol Med       Date:  2014-04-18       Impact factor: 7.376

5.  Circulating cell membrane microparticles transfer heme to endothelial cells and trigger vasoocclusions in sickle cell disease.

Authors:  Stéphane M Camus; João A De Moraes; Philippe Bonnin; Paul Abbyad; Sylvain Le Jeune; François Lionnet; Laurent Loufrani; Linda Grimaud; Jean-Christophe Lambry; Dominique Charue; Laurent Kiger; Jean-Marie Renard; Claire Larroque; Hervé Le Clésiau; Alain Tedgui; Patrick Bruneval; Christina Barja-Fidalgo; Antigoni Alexandrou; Pierre-Louis Tharaux; Chantal M Boulanger; Olivier P Blanc-Brude
Journal:  Blood       Date:  2015-03-31       Impact factor: 22.113

6.  Acellular therapeutic approach for heart failure: in vitro production of extracellular vesicles from human cardiovascular progenitors.

Authors:  Nadia El Harane; Anaïs Kervadec; Valérie Bellamy; Laetitia Pidial; Hany J Neametalla; Marie-Cécile Perier; Bruna Lima Correa; Léa Thiébault; Nicolas Cagnard; Angéline Duché; Camille Brunaud; Mathilde Lemitre; Jeanne Gauthier; Alexandra T Bourdillon; Marc P Renault; Yeranuhi Hovhannisyan; Solenne Paiva; Alexandre R Colas; Onnik Agbulut; Albert Hagège; Jean-Sébastien Silvestre; Philippe Menasché; Nisa K E Renault
Journal:  Eur Heart J       Date:  2018-05-21       Impact factor: 29.983

7.  Vascular dysfunction in diabetes: The endothelial progenitor cells as new therapeutic strategy.

Authors:  Adriana Georgescu
Journal:  World J Diabetes       Date:  2011-06-15

Review 8.  Targeting stem cell niches and trafficking for cardiovascular therapy.

Authors:  Nicolle Kränkel; Gaia Spinetti; Silvia Amadesi; Paolo Madeddu
Journal:  Pharmacol Ther       Date:  2010-10-20       Impact factor: 12.310

9.  Macrophages engulf endothelial cell membrane particles preceding pupillary membrane capillary regression.

Authors:  Ross A Poché; Chih-Wei Hsu; Melissa L McElwee; Alan R Burns; Mary E Dickinson
Journal:  Dev Biol       Date:  2015-04-24       Impact factor: 3.582

Review 10.  Extracellular Vesicles and Vascular Injury: New Insights for Radiation Exposure.

Authors:  Stéphane Flamant; Radia Tamarat
Journal:  Radiat Res       Date:  2016-07-26       Impact factor: 2.841

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.